Sanara MedTech Inc. SMTI Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sanara MedTech Inc.'s accounts receivable, credit loss expense (reversal)?
- Sanara MedTech Inc. (SMTI) reported accounts receivable, credit loss expense (reversal) of $75K in Q1 2026.
- How has Sanara MedTech Inc.'s accounts receivable, credit loss expense (reversal) changed year-over-year?
- Sanara MedTech Inc.'s accounts receivable, credit loss expense (reversal) decreased by 58.1% year-over-year, from $179.03K to $75K.
- What is the long-term trend for Sanara MedTech Inc.'s accounts receivable, credit loss expense (reversal)?
- Over 4 years (2021 to 2025), Sanara MedTech Inc.'s accounts receivable, credit loss expense (reversal) has grown at a 77.3% compound annual growth rate (CAGR), from $51.54K to $509.23K.